.png){kind=logo}
informative non-academics blog posts coming soon..
Courses section is Coming soon..
Colleges and Universities section is Coming soon..
Under Construction..
Home ❭ Questions ❭ One Liners ❭ Transition of a solid crystalline phase to another phase having the same chemical composition but a dif- ferent crystal structure.
Transition of a solid crystalline phase to another phase having the same chemical composition but a dif- ferent crystal structure.
Pharmaceutics Pharmacist Competitive Exams
Q. Transition of a solid crystalline phase to another phase having the same chemical composition but a dif- ferent crystal structure.
Ans → polymorphic transition
Explanation →
This question is taken from the test/quiz post: one liners Pharmaceutics| B.Pharmacy| Pharmacy file-6 - attemp/practice
More oneliners in - one liners Pharmaceutics| B.Pharmacy| Pharmacy file-6
Q. Usually water or low-molecular-weight alcohols or compounds, used in topical applications and in wet granulation, for the production of tablets.
Ans → moistening agents
Explanation →
Q. Dosage form comprising several elements (e.g., microspheres or coated pellets) dif- fering in the rate of drug release.
Ans → multi compartment formulation
Explanation →
Q. Consists of several different layers that are compressed on top of each other, to form a single tablet composed of two or more layers.
Ans → multilayer tablet
Explanation →
Q. Device that disperses liquids to aerosols for therapeutic use by inhalation through a mask.
Ans → nebulizer
Explanation →
Q. Greasy, semi-solid preparation for external application, often anhydrous, containing dissolved or dispersed medicaments.
Ans → ointment
Explanation →
Q. Kinetic model, where the whole body is thought of as a single compartment in which a substance is dis- tributed rapidly, achieving an equilibrium between blood and tissue immediately.
Ans → one-compartment model
Explanation →
Q. Time required to achieve the minimum effective plasma concentration following administration of the dosage form.
Ans → onset of drug action
Explanation →
Q. Process of agglomeration that converts fine powders or granules of bulk drugs and excipients into small, free-flowing, spherical, or semi-spherical units, referred to as pellets.
Ans → pelletization
Explanation →
Q. Science of preparation of drugs, dosage forms, and drug delivery systems taking into account the pharmacokinetics and pharmacodynamics of the drug as well as its physical and chemical properties.
Ans → pharmaceutics
Explanation →
Q. Solid material that exists at least in two different molecular arrangements, i.e., distinctly different crystal species.
Ans → polymorph
Explanation →
Q. Transition of a solid crystalline phase to another phase having the same chemical composition but a dif- ferent crystal structure.
Ans → polymorphic transition
Explanation →
Q. Existence of two or more different crystal structures for the same compound.
Ans → polymorphism
Explanation →
Q. Defined for powders used pharmaceutically, according to particle sizes.
Ans → powder grades
Explanation →
Q. Dry solid material consisting of many, usually free flowing, fine particles.
Ans → powder
Explanation →
More one-liners in - Pharmaceutics
Q. A Biologically active substance, which when biodistributed in the body is expected to modify one or more of its functions.
Ans → drug
Explanation →
Q. Process in which powder particles are made to aggregate to larger particles called granules.
Ans → granulation
Explanation →
Q. Name the compound with the greatest standard free energy.
Ans → Phosphoenolpyruvate
Explanation →
Q. An Obstacle such as coating or embedding, which acts as a factor controlling the rate of drug release.
Ans → diffusion barrier
Explanation →
Q. Yellowish color of the skin and mucous membranes caused by excessive bilirubin caused by a failure of the liver to effectively process the breakdown of hemoglobin
Ans → jaundice
Explanation →
Q. A group that is used to protect a functional group from unwanted reactions. After application the protecting group can be removed to reveal the original functional group.
Ans → protecting group
Explanation →
Q. electron systems in which bonding electrons are not localised between two atoms as for a single bond but are spread (delocalized) over the whole group.
Ans → delocalization
Explanation →
Q. The clones of cell produced by fusing a normal B cell with a myeloma cell that is capable of producing monoclonal antibodies indefinitely
Ans → hybridoma
Explanation →
Q. The major component of acute phase proteins used for the evaluation of acute phase response
Ans → C-reactive protein
Explanation →
Q. Visible clumping of red blood cells that can be caused by some viruses, bacteria, and certain diseases in which antibodies
Ans → hemagglutination
Explanation →
Q. A term applied an object or molecule that does not possess symmetry.
Ans → asymmetry
Explanation →
Q. Relationship between two preparations of the same drug in the same dosage form that have a similar bioavailability.
Ans → bioequivalence
Explanation →
Q. the energy required to break a particular bond by a homolytic process.
Ans → bond energy
Explanation →
Q. Dosage form in which the active ingredient is insoluble in the carrier; includes aerosols, suspensions, emulsions , and foams
Ans → disperse system
Explanation →
Q. A type of kidney infection involving the glomeruli of the nephrons
Ans → glomerulonephritis
Explanation →
Q. Name the formula that shows the number and kinds of atoms in a molecule.
Ans → Molecular Formula
Explanation →
Q. Name the cells that can assists in the organization of neurons, provides a scaffold for some aspects of neuron function, and aids in recovery from neural injury
Ans → glial cell
Explanation →
Q. The disease characterized by impairment in the absorption of neutral amino acids
Ans → Hartnup’s disease
Explanation →
Q. A Substance that absorbs sufficient moisture from the atmosphere to dissolve itself.
Ans → deliquescent
Explanation →
Q. The migration of a double bond in a 3-carbon system from carbon atoms one and two to carbon atoms two and three
Ans → allylic rearrangement
Explanation →
Q. Ascorbic acid is not synthesized in man due to lack of the enzyme
Ans → L-Gulonolactone oxidase
Explanation →
Q. A ligand that binds to a receptor and alters the receptor state resulting in a biological response.
Ans → Agonist
Explanation →
Q. Condition of being aseptic, or statistically free from living microorganisms and their spores.
Ans → sterility
Explanation →